Steel Grove Capital Advisors LLC Invests $223,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Steel Grove Capital Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 559 shares of the medical equipment provider’s stock, valued at approximately $223,000.

A number of other institutional investors also recently modified their holdings of the company. Norges Bank purchased a new stake in Intuitive Surgical in the 4th quarter valued at $1,313,238,000. WCM Investment Management LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at $575,536,000. Capital Research Global Investors purchased a new stake in Intuitive Surgical in the 1st quarter valued at $374,390,000. International Assets Investment Management LLC raised its position in Intuitive Surgical by 32,360.5% in the 4th quarter. International Assets Investment Management LLC now owns 686,865 shares of the medical equipment provider’s stock valued at $231,721,000 after buying an additional 684,749 shares during the last quarter. Finally, Assenagon Asset Management S.A. raised its position in Intuitive Surgical by 111.7% in the 1st quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after buying an additional 678,375 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Jefferies Financial Group increased their price target on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Barclays upped their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a research note on Thursday, July 18th. Evercore ISI reduced their price objective on Intuitive Surgical from $425.00 to $410.00 and set an “in-line” rating for the company in a research note on Friday, July 19th. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Finally, Piper Sandler upped their price objective on Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $438.74.

Intuitive Surgical Trading Up 1.0 %

Shares of ISRG stock traded up $4.56 on Friday, hitting $441.30. 1,196,597 shares of the stock were exchanged, compared to its average volume of 1,795,967. The firm’s 50 day moving average is $427.82 and its two-hundred day moving average is $398.55. The firm has a market capitalization of $156.82 billion, a PE ratio of 79.66, a P/E/G ratio of 4.86 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $468.78.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.18 EPS. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 175 shares of the stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00. Following the sale, the senior vice president now owns 883 shares of the company’s stock, valued at approximately $343,628.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 175 shares of the firm’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $389.16, for a total value of $68,103.00. Following the completion of the sale, the senior vice president now directly owns 883 shares in the company, valued at approximately $343,628.28. The disclosure for this sale can be found here. In the last quarter, insiders have sold 13,358 shares of company stock valued at $5,592,694. Corporate insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.